LECAP Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
LECAP Asset Management's PFE Position: Q1 2026 in Review
LECAP Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 30,750 shares — an estimated $766K sold.
LECAP Asset Management first reported a position in PFE in Q4 2023 and held it in 6 quarters. The position peaked at $2.3M in Q3 2024. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- LECAP Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- LECAP Asset Management sold 30,750 Pfizer shares in Q1 2026, an estimated $766K.
- LECAP Asset Management first reported a position in Pfizer in Q4 2023 and held it in 6 quarters.
- LECAP Asset Management's Pfizer position peaked at $2.3M in Q3 2024.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.